BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ram E, Sternik L, Klempfner R, Iakobishvili Z, Fisman EZ, Tenenbaum A, Zuroff E, Peled Y, Raanani E. Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery. Cardiovasc Diabetol. 2020;19:86. [PMID: 32534591 DOI: 10.1186/s12933-020-01069-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Babes EE, Bustea C, Behl T, Abdel-Daim MM, Nechifor AC, Stoicescu M, Brisc CM, Moisi M, Gitea D, Iovanovici DC, Bungau AF, Tit DM, Bungau SG. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed Pharmacother 2022;148:112772. [PMID: 35245735 DOI: 10.1016/j.biopha.2022.112772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kozioł M, Towpik I, Żurek M, Niemczynowicz J, Wasążnik M, Sanchak Y, Wierzba W, Franek E, Walicka M. Predictors of Rehospitalization and Mortality in Diabetes-Related Hospital Admissions. J Clin Med 2021;10:5814. [PMID: 34945110 DOI: 10.3390/jcm10245814] [Reference Citation Analysis]
3 Mistry N, Shehata N, Carmona P, Bolliger D, Hu R, Carrier FM, Alphonsus CS, Tseng EE, Royse AG, Royse C, Filipescu D, Mehta C, Saha T, Villar JC, Gregory AJ, Wijeysundera DN, Thorpe KE, Jüni P, Hare GMT, Ko DT, Verma S, Mazer CD; TRICS Investigators. Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An open-label, randomized, blinded outcome evaluation trial. Diabetes Obes Metab 2021. [PMID: 34747087 DOI: 10.1111/dom.14591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021;12:383-406. [PMID: 33889286 DOI: 10.4239/wjd.v12.i4.383] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
5 Liang B, Gu N. Treatment strategies in patients with diabetes and three-vessel coronary disease: What should we choose? Cardiovasc Diabetol 2021;20:42. [PMID: 33573627 DOI: 10.1186/s12933-021-01241-6] [Reference Citation Analysis]
6 Zhao X, Xu L, Jiang L, Tian J, Zhang Y, Wang D, Sun K, Xu B, Zhao W, Hui R, Gao R, Song L, Yuan J. Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China. Cardiovasc Diabetol 2021;20:16. [PMID: 33430864 DOI: 10.1186/s12933-020-01193-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]